Walking Clinical Trials: Transforming Medicine With Patient Precision And Privacy

By Chris Boone, Group Vice President, Research Services, Oracle Life Sciences

Advancements in personalized medicine are driving changes in clinical trials, leading to unconventional approaches like decentralized and N-of-1 trials. These single-subject trials offer personalized treatment insights based on individuals' unique health data. A future vision involves "walking trials," where continuous health data collected from wearables and digital tools inform precision medicine.

While promising for individualized care, challenges around privacy, ethics, equity, and education must be addressed. Technology companies, like Oracle, are poised to support these efforts through secure data platforms. Prioritizing privacy, ethics, and accessibility could usher in a new era of precision healthcare.